Zinc and Coronavirus Disease 2019
- PMID: 37072885
- DOI: 10.1093/cid/ciad229
Zinc and Coronavirus Disease 2019
Conflict of interest statement
Potential conflicts of interest. S. S. reports research funding from GSK/ViiV Healthcare. E. S. D. reports consultant and research support from Gilead, GSK/ViiV Healthcare, and Merck. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Comment in
-
Reply to Swindells et al.Clin Infect Dis. 2023 Aug 22;77(4):662-663. doi: 10.1093/cid/ciad228. Clin Infect Dis. 2023. PMID: 37073629 No abstract available.
Comment on
-
Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.Clin Infect Dis. 2023 Jan 13;76(2):185-191. doi: 10.1093/cid/ciac807. Clin Infect Dis. 2023. PMID: 36367144 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical